These models can serve many purposes, such as understanding disease mechanisms, disease detection, disease prediction, and in silico testing of "what-if" scenarios and even clinical trials.
Case detection, disease management and treatment were fully integrated for drug-susceptible and drug-resistant TB in 2010 ("Comprehensive TB Care for All").
Finally, PET imaging, with ligands specific to targets that are associated with a given disease state, can be used as disease state biomarkers for early disease detection, disease progression monitoring and patient phenotyping.
This review highlights current status, insights, and emerging concepts in the taxonomy, pathogenicity mechanisms, lifestyles, pathogen detection, disease diagnosis, and management and progress in the genomics of plant pathogenic bacteria.
Moreover, aberrant DNA methylation in host and HPV genome can be utilized not only as biomarkers for early detection, disease progression, diagnosis and prognosis of cervical cancer but also to design effective therapeutic strategies.
Non-invasive molecular imaging agents that target tumor-related integrin receptors will play an important role in earlier cancer detection, disease staging, and management [16], [17].
